These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 34125319)
1. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities. Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319 [TBL] [Abstract][Full Text] [Related]
2. The microbiome and gynecologic cancer: cellular mechanisms and clinical applications. Chalif J; Wang H; Spakowicz D; Quick A; Arthur EK; O'Malley D; Chambers LM Int J Gynecol Cancer; 2024 Feb; 34(2):317-327. PubMed ID: 38088183 [TBL] [Abstract][Full Text] [Related]
3. The microbiome and gynaecological cancer development, prevention and therapy. Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434 [TBL] [Abstract][Full Text] [Related]
4. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Chase D; Goulder A; Zenhausern F; Monk B; Herbst-Kralovetz M Gynecol Oncol; 2015 Jul; 138(1):190-200. PubMed ID: 25957158 [TBL] [Abstract][Full Text] [Related]
5. Harnessing the power within: engineering the microbiome for enhanced gynecologic health. Brennan C; Chan K; Kumar T; Maissy E; Brubaker L; Dothard MI; Gilbert JA; Gilbert KE; Lewis AL; Thackray VG; Zarrinpar A; Knight R Reprod Fertil; 2024 Apr; 5(2):. PubMed ID: 38513356 [TBL] [Abstract][Full Text] [Related]
6. Diet and gut microbiome interactions in gynecologic cancer. AlHilli MM; Bae-Jump V Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758 [TBL] [Abstract][Full Text] [Related]
7. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review. Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962 [TBL] [Abstract][Full Text] [Related]
8. Microbes in gynecologic cancers: Causes or consequences and therapeutic potential. Wahid M; Dar SA; Jawed A; Mandal RK; Akhter N; Khan S; Khan F; Jogaiah S; Rai AK; Rattan R Semin Cancer Biol; 2022 Nov; 86(Pt 2):1179-1189. PubMed ID: 34302959 [TBL] [Abstract][Full Text] [Related]
9. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research. McKenzie ND; Hong H; Ahmad S; Holloway RW Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575 [TBL] [Abstract][Full Text] [Related]
10. The impact of the female genital tract microbiome in women health and reproduction: a review. Punzón-Jiménez P; Labarta E J Assist Reprod Genet; 2021 Oct; 38(10):2519-2541. PubMed ID: 34110573 [TBL] [Abstract][Full Text] [Related]
11. Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value. Wu J; Li J; Yan M; Xiang Z NPJ Biofilms Microbiomes; 2024 Oct; 10(1):104. PubMed ID: 39389989 [TBL] [Abstract][Full Text] [Related]
12. Beyond the reproductive tract: gut microbiome and its influence on gynecological health. Pérez-Prieto I; Rodríguez-Santisteban A; Altmäe S Curr Opin Clin Nutr Metab Care; 2024 Jun; 36(3):134-147. PubMed ID: 38656809 [TBL] [Abstract][Full Text] [Related]
13. Pilot Study of Vaginal Microbiome Using QIIME 2™ in Women With Gynecologic Cancer Before and After Radiation Therapy. Bai J; Jhaney I; Daniel G; Watkins Bruner D Oncol Nurs Forum; 2019 Mar; 46(2):E48-E59. PubMed ID: 30767956 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the Role of Human Gastrointestinal Microbiota in the Pathogenesis of Vaginal Infection and Cervical Cancer. Wang J; Yang Z; Li W J Environ Pathol Toxicol Oncol; 2020; 39(4):365-373. PubMed ID: 33389908 [TBL] [Abstract][Full Text] [Related]
15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [TBL] [Abstract][Full Text] [Related]
16. The female reproductive tract microbiotas, inflammation, and gynecological conditions. Gholiof M; Adamson-De Luca E; Wessels JM Front Reprod Health; 2022; 4():963752. PubMed ID: 36303679 [TBL] [Abstract][Full Text] [Related]
17. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy. Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914 [TBL] [Abstract][Full Text] [Related]
18. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections. García-Peñarrubia P; Ruiz-Alcaraz AJ; Martínez-Esparza M; Marín P; Machado-Linde F Hum Reprod Update; 2020 Feb; 26(2):214-246. PubMed ID: 32108227 [TBL] [Abstract][Full Text] [Related]
19. The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine. Rizzo AE; Gordon JC; Berard AR; Burgener AD; Avril S J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34208337 [TBL] [Abstract][Full Text] [Related]
20. Insights into the Microbial Composition of Intratumoral, Reproductive Tract, and Gut Microbiota in Ovarian Cancer Patients. Zhou Q; Meng Q Adv Exp Med Biol; 2024; 1452():107-118. PubMed ID: 38805127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]